US authorises Pfizer oral COVID-19 treatment for at-home use
Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness
Subscribing is the best way to get our best stories immediately.